Recent Press Releases

Cortendo Announces Plans to Redomicile the Cortendo Group's Parent Company from Sweden to Ireland By Means of an Exchange Offer

GÖTEBORG, Sweden & Trevose, Pa.--(BUSINESS WIRE)--Cortendo AB (publ) [ticker: CORT on NOTC-A] (the "Company") today announced its intention to relocate the parent company of the Cortendo...

Teva and Immuneering Announce Teva's Purchase of 51% Equity Share of Genomic-Analysis Company

Transaction underscores Teva's "personalized-medicine" approach to treatment optimization across a spectrum of specialty and generics development programs and lifecycle management...

Galleon Pharmaceuticals Names Joseph Oliveto as Chief Executive Officer

- Former CEO of Chelsea Therapeutics to Lead Galleon's Development and Commercialization of Pharmaceuticals for Sleep Apnea and Related Disorders - HORSHAM, Pa.--(BUSINESS WIRE)--Galleon...

Blood Publishes Phase III Data on Baxalta's Investigational Treatment for Von Willebrand Disease, the Most Common Type of Inherited Bleeding Disorder

Von Willebrand patients may experience slower blood clot formation and prolonged bleeding due to insufficient or defective factor1 In the study, 100 percent of patients treated with Baxalta's...

Bristol-Myers Squibb Establishes Collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) Program in the U.S.

Company enters into a collaboration agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute as part of...

Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies

SAN DIEGO, Aug. 3, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) announced today that it has entered into an exclusive licensing agreement to develop and commercialize...

Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome

Telotristat Etiprate has FDA Fast-Track, Orphan Drug Status THE WOODLANDS, Texas, Aug. 3, 2015 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (LXRX) today announced that the pivotal TELESTAR Phase...

Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset

Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset FST-100, if approved, would be the first to treat both bacterial and viral eye...

AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases

CARLSBAD, Calif., Aug. 3, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and AstraZeneca today announced a strategic collaboration to discover and develop antisense therapies for...

In Interim Results from Phase 3 Study, Merck's Investigational Ebola Vaccine Efficacious; Study is Continuing

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (known as MSD outside the US and Canada) said today that its investigational Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100 percent efficacy in...

Kailos Genetics Hires Cheri Walker As Chief Financial Officer

Walker to support corporate strategic development following the launch of Praxis, a consumer-directed gene-based test HUNTSVILLE, Ala.--(BUSINESS WIRE)--Kailos Genetics, a personalized medicine...

Otic Pharma Appoints Gregory J. Flesher As Chief Executive Officer

IRVINE, Calif. and REHOVOT, Israel, July 27, 2015 /PRNewswire/ -- Otic Pharma Ltd, a privately held pharmaceutical company focused on developing innovative therapies for ear, nose, and throat...

CTI BioPharma Appoints Bruce J. Seeley As Executive Vice President And Chief Commercial Officer

SEATTLE, July 27, 2015 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the appointment of Bruce J. Seeley as Executive Vice President and Chief Commercial...

Heat Biologics Announces Promotions Of Taylor Schreiber, M.D., Ph.D., To Chief Scientific Officer, And Melissa Price, Ph.D., To Vice President Of Product Development

DURHAM, N.C., July 27, 2015 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ("Heat" or the "Company") (NASDAQ:HTBX), a clinical stage biopharmaceutical company focused on the...

Keryx (KERX) Appoints Scott A. Holmes As Chief Financial Officer

BOSTON, July 27, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the appointment of Scott A. Holmes to Chief Financial Officer effective immediately. Mr. Holmes...

GlySure Appoints Roger Moody As Chief Executive Officer

ABINGDON, England--(BUSINESS WIRE)--GlySure Limited, a leader in continuous glucose monitoring for critical care patients, today announced the appointment of Roger Moody as Chief Executive Officer....

Vitae Pharma (VTAE) Appoints Dr. John M. Leonard To Board Of Directors

FORT WASHINGTON, Pa., July 29, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), a clinical-stage biotechnology company, today announced the appointment of John M. Leonard, M.D., to...

Enzymotec Announces The Appointment Of Tamar Howson To Its Board Of Directors

MIGDAL HA'EMEQ, Israel, July 30, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...

ChemoCentryx, Inc. (CCXI) Announces Changes To Its Board Of Directors

MOUNTAIN VIEW, Calif., July 30, 2015 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and...

Loxo Oncology (LOXO) Appoints Industry Veteran Tim Mayleben To Board Of Directors

STAMFORD, Conn., July 30, 2015 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company focused on the discovery, development, and commercialization of targeted cancer...